@article{3a23141c1ba34eb0b84388f691196ee8,
title = "Pregnancy outcomes in patients exposed to baricitinib in clinical trials and during postmarketing surveillance",
author = "Bianca Bergamini and Julien Seneschal and Meyers, \{Kristin J.\} and Frederick Durand and Ewa Haladyj and Gerard Espinosa and Thyssen, \{Jacob P.\}",
note = "Funding Information: This study was sponsored by Eli Lilly and Company. Funding Information: The authors wish to thank the study participants, investigators, trial staff, and healthcare practitioners for their contributions to the Eli Lilly global safety database. Writing support was provided by Fionnuala Murphy PhD and Dominika Kennedy PhD; medical review was provided by Katrin Holzwarth MD; and statistical review was provided by Xiaoyu Lu PhD, all employees of Eli Lilly and Company. Editorial support was provided by Mikaella Bernabe and Anthony Marca of Certara Synchrogenix. This study was sponsored by Eli Lilly and Company.",
year = "2023",
month = dec,
doi = "10.1093/bjd/ljad279",
language = "English",
volume = "189",
pages = "767--769",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Oxford University Press",
number = "6",
}